AVIR Institutional Ownership

Atea Pharmaceuticals, Inc.

Latest close $4.75 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing May 6, 2026

Public consensus preview Accumulation leaning 61/100 institutional research score

2 tracked institutions Latest filing May 6, 2026

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$2.46 52-week high$6.45

Latest close $4.75 57.4% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Mar 31, 2026

BlackRock Legacy Jan 24, 2024 filed

Fidelity / FMR May 6, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 3 parsed filing(s)

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
Fidelity / FMR CIK0000315066	Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment	Earliest Schedule 13G amendment found	12.0K	15.00%	$5.38	$5.65	$4.75
BlackRock Legacy CIK0001364742	Dec 31, 2023 observed Jan 24, 2024 filed · 24d Schedule 13G amendment	Reported accumulation	9.4M +605.9K	11.30% +0.70 pts			$4.75
BlackRock Legacy CIK0001364742	Oct 31, 2023 observed Nov 7, 2023 filed · 7d Schedule 13G amendment	Earliest Schedule 13G amendment found	8.8M	10.60%			$4.75

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

UCB UNITED COMMUNITY BANKS INC 61/100 Accumulation leaning CHTR CHARTER COMMUNICATIONS INC-A 61/100 Accumulation leaning NTR NUTRIEN LTD 61/100 Accumulation leaning RVLV Revolve Group, Inc. 61/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026